Rebalance’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$367K Sell
2,316
-189
-8% -$28.1K 0.02% 86
2026
Q1
$367K Buy
2,505
+9
+0.4% +$1.39K 0.02% 84
2025
Q4
$386K Buy
2,496
+10
+0.4% +$1.5K 0.02% 85
2025
Q3
$346K Buy
2,486
+10
+0.4% +$1.35K 0.02% 85
2025
Q2
$334K Buy
2,476
+11
+0.4% +$1.49K 0.02% 82
2025
Q1
$360K Buy
2,465
+208
+9% +$30.2K 0.03% 77
2024
Q4
$311K Buy
2,257
+10
+0.4% +$1.46K 0.02% 88
2024
Q3
$346K Buy
2,247
+8
+0.4% +$1.21K 0.03% 78
2024
Q2
$326K Buy
2,239
+9
+0.4% +$1.29K 0.03% 74
2024
Q1
$329K Buy
2,230
+8
+0.4% +$1.15K 0.03% 76
2023
Q4
$303K Buy
+2,222
New +$289K 0.03% 75

Other funds holding XLV

Rebalance's XLV Position: Q2 2026 in Review

Rebalance reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 7.5% in Q2 2026, selling an estimated $28.1K and leaving 2,316 shares worth $367K. The position accounts for 0.02% of the portfolio, ranked #86.

Rebalance first reported a position in XLV in Q4 2023 and has held it in 11 quarters since. The position peaked at $386K in Q4 2025. 1,852 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Rebalance held 2,316 shares of State Street Health Care Select Sector SPDR ETF worth $367K as of Q2 2026.
  • Rebalance sold 189 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $28.1K.
  • State Street Health Care Select Sector SPDR ETF made up 0.02% of Rebalance's portfolio in Q2 2026, its #86 holding.
  • Rebalance first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2023 and has held it in 11 quarters since.
  • Rebalance's State Street Health Care Select Sector SPDR ETF position peaked at $386K in Q4 2025.
  • 1,852 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Rebalance's 13F filing for Q2 2026, filed 16 Jul 2026.